Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Zhōnghuá xuèyèxué zázhì, 2024-03, Vol.45 (3), p.299-302
2024
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Chronic myeloid leukemia with e6a2 fusion gene: a case report and literature review
Ist Teil von
  • Zhōnghuá xuèyèxué zázhì, 2024-03, Vol.45 (3), p.299-302
Ort / Verlag
China
Erscheinungsjahr
2024
Quelle
Elektronische Zeitschriftenbibliothek - Freely accessible e-journals
Beschreibungen/Notizen
  • Chronic myeloid leukemia (CML) with e6a2 transcript type is very rare in clinic,which is usually related to disease aggressiveness. Its clinical characteristics and relationship with tyrosine kinase inhibitor efficacy are still unclear. In this paper, the clinical characteristics and related laboratory tests of a patient with e6a2 fusion gene positive CML characterized by multiple osteolytic bone destruction throughout the body and eosinophil infiltration in gastrointestinal tract, lymph nodes and other organs were retrospectively analyzed, and the relevant literature was reviewed. The patient was Ph chromosome positive with chromosome +8, and the common BCR::ABL1 transcript of CML was negative, but e6a2 transcript was positive detected by RT-PCR. The patient was treated with dasatinib 100 mg/d. Three months later, the patients achieved CHR, CCyR and MR4.0. However, the e6a2 transcript is very rare in clinical practice, and more cases of e6a2 transcript need to be studied to clarify its clinical characteristi
Sprache
Chinesisch
Identifikatoren
ISSN: 0253-2727
DOI: 10.3760/cma.j.cn121090-20230930-00156
Titel-ID: cdi_proquest_miscellaneous_3052593947

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX